Vanda Pharmaceuticals gains after FDA lifts partial clinical hold on motion sickness treatment

Vanda Pharmaceuticals

04/12/2025 22:02

** Shares of Vanda Pharmaceuticals VNDA.O rise nearly 7% to about $5.55 after the bell

** U.S. Food and Drug Administration lifts partial clinical hold on co's tradipitant for motion sickness

** This decision allows Vanda to extend clinical studies of tradipitant

** Stocks up 8.5% YTD

 (Reporting by Parth Chandna)

 ((Parth.Chandna@thomsonreuters.com;))